Furthermore, the combination of PARP inhibitors with temozolomide in Ewing’s sarcoma [23] or camptothecin in childhood neuroblastoma [24] shows stronger synergetic effects compared to the cisplatin case. This evidence concerns the gene PARP1 and neuroblastoma.